CVS HEALTH Corp Cash & Equivalents 2006-2025 | CVS
What is cash & equivalents?
Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.
What is CVS HEALTH Corp's current cash & equivalents?
CVS HEALTH Corp (CVS) annual cash & equivalents for 2025 was $8.45B, a 1.55% decline from 2024. CVS HEALTH Corp cash & equivalents for the quarter ending December 31, 2025 was $8.45B.
What was CVS HEALTH Corp's cash & equivalents in 2024?
CVS HEALTH Corp annual cash & equivalents for 2024 was $8.59B, a 4.76% increase from 2023.
What was CVS HEALTH Corp's cash & equivalents in 2023?
CVS HEALTH Corp annual cash & equivalents for 2023 was $8.20B, a 36.69% decline from 2022.
What is CVS HEALTH Corp's 5-year cash & equivalents CAGR?
CVS HEALTH Corp cash & equivalents grew at a compound annual growth rate (CAGR) of 1.48% from FY2020 to FY2025, going from $7.85B to $8.45B over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $8.45B | -1.5% | 10-K |
| FY2024 | $8.59B | +4.8% | 10-K |
| FY2023 | $8.20B | -36.7% | 10-K |
| FY2022 | $12.95B | +37.6% | 10-K |
| FY2021 | $9.41B | +19.8% | 10-K |
| FY2020 | $7.85B | +38.2% | 10-K |
| FY2019 | $5.68B | +40.0% | 10-K |
| FY2018 | $4.06B | +139.3% | 10-K |
| FY2017 | $1.70B | -49.7% | 10-K |
| FY2016 | $3.37B | +37.1% | 10-K |
| FY2015 | $2.46B | -0.9% | 10-K |
| FY2014 | $2.48B | -39.3% | 10-K |
| FY2013 | $4.09B | +197.4% | 10-K |
| FY2012 | $1.38B | -2.7% | 10-K |
| FY2011 | $1.41B | -1.0% | 10-K |
| FY2010 | $1.43B | +31.4% | 10-K |
| FY2009 | $1.09B | -19.7% | 10-K |
| FY2008 | $1.35B | +28.0% | 10-K |
| FY2007 | $1.06B | +99.2% | 10-K |
| FY2006 | $530.0M | - | 10-K |